Tolerability of Saxagliptin in Patients with Inadequately Controlled Type 2 Diabetes: Results from 6 Phase III Studies

BACKGROUND: Oral antihyperglycemic drugs used to treat type 2 diabetes mellitus (T2DM) vary in safety and tolerability. Treatment-related hypoglycemia and weight gain can exacerbate underlying disease. OBJECTIVES: To evaluate the tolerability of saxagliptin using data from phase III clinical trials....

Descripción completa

Detalles Bibliográficos
Autor principal: Davidson, Jaime A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437547/
https://www.ncbi.nlm.nih.gov/pubmed/24456313
http://dx.doi.org/10.18553/jmcp.2014.20.2.120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437547/
https://www.ncbi.nlm.nih.gov/pubmed/24456313
http://dx.doi.org/10.18553/jmcp.2014.20.2.120

Ejemplares similares